Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
Year: 2024
Type: article
Study design: Clinical Trial
Source: The Lancet
Authors: Alberto Bossi, Stéphanie Foulon, Xavier Maldonado, Paul Sargos, Ray MacDermott, Paul Kelly, Aude Fléchon, Bertrand Tombal, Stephane Supiot, Dominik Berthold, Philippe Ronchin, Gabriel Kacso, Naji Salem, Fabio Calabro, Jean-François Berdah, Ali Hasbini, Marlon Silva, Jihane Boustani, Hélène Ribault, Karim Fizazi
Institutions: Institut Gustave Roussy, Inserm, Vall d'Hebron Hospital Universitari, Institut Bergonié, Cancer Trials Ireland, St. Vincent's University Hospital, Cork University Hospital, Centre Léon Bérard, Cliniques Universitaires Saint-Luc, Institut de Cancérologie de l'Ouest, Centre Hospitalier Universitaire Vaudois, Centre Azuréen de Cancérologie, Iuliu Hațieganu University of Medicine and Pharmacy, Institut Paoli-Calmettes, Azienda Ospedaliera San Camillo-Forlanini, Clinique des Cèdres, Clinique Pasteur, Centre François Baclesse, Centre Georges François Leclerc, UniCancer Group
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funders: Institut National Du Cancer, Ipsen
OpenAlex ID: W4404580883